What’s Next? Transitioning from EUA to IVD Assays for SARS-CoV-2

This webinar provides laboratories a manufacturer-agnostic, CAP and NY State perspective on the transition from EUA to 510(k) assays for SARS-CoV-2. The goal is to help labs begin thinking through scenarios and important considerations to help them prepare for these upcoming transitions.

Presenters:

• Allison McMullen, PhD, Scientific Affairs Manager
• David Peaper, MD, PhD, Associate Professor of Laboratory Medicine; Director, Clinical Microbiology Laboratory, YNHH; Director, Medical Microbiology Fellowship Program; Director, Virology Reference Laboratory, VACT
• Kimberlee Musser, PhD, Clinical Director, New York State Department of Health Wadsworth Center, David Axelrod Institute
  

Duration:

• 57 minutes